Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FKRWN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,501
Award facts
- Contract value 100% obligated
- $26,501.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for $26.5K to supply Dupixent 300 mg/2 ml pen injectors. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9M comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering specialty pharmaceuticals, brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This award for Dupixent, a specialty immunology treatment, exemplifies the company's role in supplying specialized medical commodities essential to military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FKRWN?
SPE2DB26FKRWN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FKRWN worth?
The government has obligated $26,501 on SPE2DB26FKRWN.
Is contract SPE2DB26FKRWN an order under another contract?
Yes. SPE2DB26FKRWN is a delivery order under SPE2DB24D3014, an indefinite delivery contract.
Was contract SPE2DB26FKRWN competed?
The extent of competition for SPE2DB26FKRWN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award